NAIR MADHAVAN G has a total of 16 patent applications. Its first patent ever was published in 1990. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are SCHERING AKTI ENGESELLSCHAFT, KOCHI MUTSUYUKI and CONFLUENCE LIFE SCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 4 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Nair Madhavan G | 16 |
#2 | Abraham Ann | 3 |
#3 | Krumdieck Carlos L | 2 |
#4 | Koopman William J | 2 |
#5 | Alarcon Graciela | 2 |
#6 | Castaneda Oswaldo | 2 |
#7 | Abraham Ann E- | 1 |
#8 | Li Shu W | 1 |
#9 | Liu Li | 1 |
Publication | Filing date | Title |
---|---|---|
US2013018062A1 | Pain therapy with metabolism blocked antifolates | |
US2010260825A1 | Antifolates for the treatment of cardiovascular, inflammatory, neoplastic, autoimmune and related diseases in sublingual dosage units, film strips, or skin patches | |
US2010239646A1 | Sublingual methotrexate and methotrexate patches | |
EP1535911A1 | Metabolically inert anti-inflammatory and anti-tumor antifolates | |
WO9640680A1 | Novel non-classical folate analogue inhibitors of glycinamide ribonucleotide formyltransferase (garft) | |
US5260296A | Thiophene substituted antitumor antifolates | |
US5145854A | 1-formyl-5,8,10-trideazafolates | |
WO9114433A1 | 10-deazaaminopterin: a new arthritis remittive drug | |
US5073554A | Two non-polyglutamatable antifolates | |
US4996207A | Three new non-polyglutamatable deazaaminopterins |